STRATA Skin Sciences, Inc. (SSKN)
OTCMKTS · Delayed Price · Currency is USD
0.0055
+0.0005 (10.00%)
At close: Jul 29, 2026
STRATA Skin Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -6.26 | -10.09 | -10.83 | -5.55 | -2.71 |
Depreciation & Amortization | 4.47 | 5.31 | 5.9 | 5.69 | 4.09 |
Other Amortization | 0.16 | 0.15 | 0.14 | 0.16 | 0.04 |
Loss (Gain) From Sale of Assets | 0.09 | 0.05 | 0.07 | 0.05 | 0.14 |
Asset Writedown & Restructuring Costs | - | 4.27 | 2.28 | - | - |
Stock-Based Compensation | 0.64 | 0.43 | 1.3 | 1.47 | 1.64 |
Provision & Write-off of Bad Debts | 0.13 | -0.18 | -0.11 | 0.11 | 0 |
Other Operating Activities | -1.14 | -0.02 | 0.79 | 0.04 | -2.02 |
Change in Accounts Receivable | 1 | -0.63 | 0.14 | -1.15 | -0.49 |
Change in Inventory | -0.29 | 0.57 | 0.69 | -1.34 | -0.05 |
Change in Accounts Payable | 0.35 | -0.95 | -0.1 | 0.6 | 0.06 |
Change in Unearned Revenue | -0.12 | -0.06 | -0.47 | -0.64 | -0.44 |
Change in Other Net Operating Assets | -1.83 | 1.35 | -0.33 | -0.36 | 1.25 |
Operating Cash Flow | -2.79 | 0.19 | -0.52 | -0.92 | 1.51 |
Operating Cash Flow Growth | - | - | - | - | -28.05% |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -1.47 | -1.64 | -5.02 | -3.74 | -3.65 |
Cash Acquisitions | - | - | - | -0.63 | -3.47 |
Investing Cash Flow | -1.47 | -1.64 | -5.02 | -4.37 | -7.13 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | 7 | - | 8 |
Total Debt Issued | - | - | 7 | - | 8 |
Short-Term Debt Repaid | - | - | - | - | -7.28 |
Long-Term Debt Repaid | - | - | - | - | -0.5 |
Total Debt Repaid | - | - | - | - | -7.78 |
Net Debt Issued (Repaid) | - | - | 7 | - | 0.23 |
Issuance of Common Stock | 3.58 | 1.94 | - | - | - |
Other Financing Activities | - | -0.02 | -0.14 | -0.5 | -0.13 |
Financing Cash Flow | 3.58 | 1.93 | 6.86 | -0.5 | 0.09 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -0.68 | 0.48 | 1.32 | -5.79 | -5.53 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4.26 | -1.45 | -5.54 | -4.66 | -2.15 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -13.88% | -4.31% | -16.60% | -12.89% | -7.16% |
Free Cash Flow Per Share | -0.92 | -0.38 | -1.59 | -1.34 | -0.63 |
Levered Free Cash Flow | -1.33 | 0.48 | -3.04 | -1.56 | 8.78 |
Unlevered Free Cash Flow | -0.27 | 1.65 | -2.15 | -1.13 | 8.94 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 1.81 | 1.97 | 1.42 | 0.74 | 0.22 |
Cash Income Tax Paid | 0.01 | 0.01 | 0.02 | 0.02 | - |
Change in Working Capital | -0.89 | 0.28 | -0.07 | -2.89 | 0.32 |